When was Windham Life Sciences Partners IV, L.P.'s most recent SEC filing?

Windham Life Sciences Partners IV, L.P.'s most recent Form D filing was on 2026-11-09.

How many investors does Windham Life Sciences Partners IV, L.P. have?

The most recent Form D filing lists 83 investor(s).

What type of securities does Windham Life Sciences Partners IV, L.P. offer?

Windham Life Sciences Partners IV, L.P.'s SEC Form D filings indicate equity offerings.

Windham Life Sciences Partners IV, L.P.

CIK: 0002153661·Pooled Investment Fund·NEW YORK, NY·Limited Partnership·Founded 2023

Reported Sold

N/A

Total Filings

Identified Offerings

Last Filed

Nov 9, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 1 unlinked amendment excluded.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Nov 9, 2026Form D/A — Amendment

Reported sold: $58,625,000 · Target: $200,000,000

No verified predecessor available.

Rule 506(b)·83 investors·Section 3(c), Section 3(c)(1), Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

N/A

Amendment Rate

100%

Latest reported sold across 0 identified offerings

N/A

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

1 unlinked amendment excluded.

Key People

Adam E Fine

Related Person

Appears on 1 filing

Windham Life Sciences Partners General Partner IV, LLC

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 9, 2026	Amendment	$200,000,000	$58,625,000	83

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Emerging Innovation Fund LLC, Series A

Pooled Investment Fund

Offering target: $100,000,000

Filed Nov 10, 2026